Research that is free to access for all investors. Companies commission these providers to write research about them.
Brokers who write research on their corporate clients and make it available through our main bundle offering.
Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.
Event in Progress:
Arecor Therapeutics PLC (AREC:LON) | 77.5 0 0.0% | Mkt Cap: 29.3m
Dr Mike Mitchell | Julie Simmonds
14 pages
Companies: GNS FDBK AMS SN/ EKF EAH ANCR FUM TSTL HIK CVSG SCLP COG HVO CTEC OXB DXRX NIOX SPI IHC AVCT HCM OHGR AREC MXCT ONT OPT
Companies: SYGGF INDVN 4BB ACSO PRM SUN AMS ARBB SN/ EKF EAH SAR TSTL IPO CNSL SDI TRX SCLP HVO CTEC FAB SBTX POLX VLG IXI VAL SPI PHP STX CREO SYNC AREC ONT SLN IMCR ABDX
Companies: Arecor Therapeutics PLC
Companies: TXG SYGGF INDVN Z29 TXG FARN 4BB PRM SUN AMS SN/ OMG EKF EAH SAR TSTL IPO CNSL SDI TRX SCLP HVO CTEC FAB SBTX POLX VLG IXI VAL SPI PHP STX CREO SYNC AREC ONT SLN IMCR ABDX
